Carrascosa JM, Vanaclocha F, Caloto T, Echave M, Oyagüez I, Tencer T
Cost-utility analysis of apremilast for the treatment of moderate to severe psoriasis in Spain
18th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Milan, Italia. 7-11 nov 2015
Almodóvar R, Gonzalez C, Caloto T, Elías I, Oyagüez I, Tencer T
Budget impact analysis of apremilast in patients with psoriatic arthritis in Spain
18th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Milan, Italia. 7-11 nov 2015
Echave M, Ojanguren ME, Elías I, De Andrés-Nogales F, Oyagüez I, Casado MÁ, Crespo C
Cost-effectiveness of tiotropium in the treatment of patients with asthma
18th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Milan, Italia. 7-11 nov 2015
Echave M, Oyagüez I, Lamas MJ, Rubio M, Subirá R
Aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer: cost-effectiveness based on VELOUR Best Efficacy Subgroup post-hoc analysis
18th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Milan, Italia. 7-11 nov 2015
Rodríguez-González Moro JM, Menendez R, Campins M, Lwoff N, Oyagüez I, Echave M, Rejas J, Antoñanzas F
Cost-effectiveness of a 13-valent conjugate pneumococcal vaccination program in COPD patients aged 50+ years in Spain
18th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Milan, Italia. 7-11 nov 2015
Torres C, Oyagüez I, Prieto L, Rodriguez G, Nieto E, Levitch R, Aguilar A, Esteban J
Costs analysis of PCR Unvyero TM i60-ITI technique for detecting microorganisms in patients with suspected chronic infection at musculoskeletal implants
18th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Milan, Italia. 7-11 nov 2015
Ortega-Joaquin N, Elías I, de la Cueva P, Del Pozo LJ, Boada A, Moreno D, Aguilar M, Mosquera E, Mirada A, Gibbons C, Oyagüez I
Cost-effectiveness of ingenol mebutate versus imiquimod 5% for actinic keratosis treatment in Spain
18th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Milan, Italia. 7-11 nov 2015
Elias I, Ortega-Joaquin N, Aguilar M, Moreno D, Boada A, Del Pozo LJ, De la Cueva P, Mirada A, Mosquera E, Gibbons C, Oyagüez I
Cost-utility analysis of ingenol mebutate versus diclofenac 3% for actinic keratosis treatment in Spain
18th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Milan, Italia. 7-11 nov 2015
Solé A, Poveda JL, Girón R, Prados C, De Gracia J, Casado MA